{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-026903","form_type":"8-K","ticker":"SGMO","cik":"0001001233","company_name":"SANGAMO THERAPEUTICS, INC","filed_at":"2024-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.791732+00:00","generated_at":"2026-06-01T06:08:30.241291+00:00","sec_items":["5.02","5.03","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Sangamo shareholders approve increase in authorized shares and equity plan share reserve at annual meeting","bullets":["Authorized common stock increased from 640M to 960M shares (320M increase).","2018 Equity Incentive Plan amended to add 11M shares to the reserve (total available now ~49.3M plus returning shares).","All nine director nominees elected; advisory 'say-on-pay' passed with 101.3M votes for vs 15.1M against.","Ratification of Ernst & Young as independent auditor for FY2024 approved with 151.1M votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-026903","json":"https://secwatch.observer/filing/0001628280-24-026903.json","markdown":"https://secwatch.observer/filing/0001628280-24-026903.md","text":"https://secwatch.observer/filing/0001628280-24-026903.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1001233/000162828024026903/0001628280-24-026903-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1001233/000162828024026903/sgmo-20240604.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:08:30.241291+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}